NAA10

Chr XX-linkedXLDXLR

N-alpha-acetyltransferase 10, NatA catalytic subunit

Also known as: ARD1, ARD1A, ARD1P, DXS707, LZMS, MAA, MCOPS1, NATD

N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]

Primary Disease Associations & Inheritance

Microphthalmia, syndromic 1MIM #309800
X-linked
Ogden syndromeMIM #300855
XLDXLR
UniProtN-terminal acetyltransferase deficiency
523
ClinVar variants
183
Pathogenic / LP
0.76
pLI score
0
Active trials
Clinical SummaryNAA10
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.76) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
183 Pathogenic / Likely Pathogenic· 81 VUS of 523 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.52LOEUF
pLI 0.762
Z-score 2.49
OE 0.11 (0.040.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
2.41Z-score
OE missense 0.33 (0.250.44)
33 obs / 101.2 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.11 (0.040.52)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.33 (0.250.44)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.06
01.21.6
LoF obs/exp: 1 / 9.1Missense obs/exp: 33 / 101.2Syn Z: -0.31

ClinVar Variant Classifications

523 submitted variants in ClinVar

Classification Summary

Pathogenic158
Likely Pathogenic25
VUS81
Likely Benign48
Benign30
Conflicting16
158
Pathogenic
25
Likely Pathogenic
81
VUS
48
Likely Benign
30
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
8
148
0
158
Likely Pathogenic
1
18
6
0
25
VUS
1
52
28
0
81
Likely Benign
1
3
24
20
48
Benign
0
1
22
7
30
Conflicting
16
Total58222827358

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NAA10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

NAA10-related syndromic developmental disorder

definitive
Monoallelic XLoss Of FunctionAltered Gene Product Structure
Dev. DisordersEye
G2P ↗
missense variantinframe deletion3 prime UTR variantinframe insertionsplice acceptor variant NMD escapingsplice donor variant NMD escapingframeshift variant NMD escaping

NAA10-related syndromic microphthalmia

moderate
Monoallelic X HemizygousLoss Of FunctionAbsent Gene Product, Altered Gene Product Structure, Decreased Gene Product Level
Dev. DisordersEye
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Microphthalmia, syndromic 1

MIM #309800

Molecular basis of disorder known

X-linked

Ogden syndrome

MIM #300855

Molecular basis of disorder known

X-linked dominantX-linked recessive
Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →